Canada markets closed

Can-Fite BioPharma Ltd. (CANF)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
2.2500-0.1000 (-4.26%)
At close: 04:00PM EDT
2.3000 +0.05 (+2.22%)
After hours: 07:15PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
817
743
810
853
763
-
Operating Expenses
Research Development
8,410
5,983
7,763
9,850
11,951
-
Selling General and Administrative
3,448
2,955
3,143
3,845
2,951
-
Total Operating Expenses
11,858
8,938
10,906
13,695
14,902
-
Operating Income or Loss
-11,041
-8,195
-10,096
-12,842
-14,139
-
Interest Expense
-
-
-
-
363
435
Total Other Income/Expenses Net
69
69
-283
221
38
-
Income Before Tax
-11,272
-7,634
-10,173
-12,615
-14,443
-
Income Tax Expense
0
0
0
0
0
-
Income from Continuing Operations
-11,272
-7,634
-10,173
-12,615
-14,443
-
Net Income
-11,272
-7,634
-10,173
-12,615
-14,443
-
Net Income available to common shareholders
-13,862
-7,634
-10,173
-15,205
-15,158
-
Basic EPS
-1.48
-
-3.00
-9.00
-12.00
-42.00
Diluted EPS
-1.48
-
-3.00
-9.00
-12.00
-42.00
Basic Average Shares
3,704
-
2,719
1,844
1,195
286.366
Diluted Average Shares
3,704
-
2,719
1,844
1,195
286.366